336.42
BATS BZX Real-Time Price
As of 12:09pm ET
 +2.68 / +0.80%
Today’s Change
219.13
Today|||52-Week Range
459.75
+3.50%
Year-to-Date
Here's Why Investors Should Bet on Abiomed (ABMD) Stock Now
9:47am / Zacks.com - Paid Partner Content
3 Reasons Growth Investors Will Love Abiomed (ABMD)
Jan 18 / Zacks.com - Paid Partner Content
Why Abiomed (ABMD) is Poised to Beat Earnings Estimates Again
Jan 21 / Zacks.com - Paid Partner Content
Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know
Jan 16 / Zacks.com - Paid Partner Content
Here's Why Abiomed (ABMD) is a Great Momentum Stock to Buy
Jan 21 / Zacks.com - Paid Partner Content
Company News For Jan 9, 2019
Jan 09 / Zacks.com - Paid Partner Content
Top Ranked Momentum Stocks to Buy for January 21st
Jan 21 / Zacks.com - Paid Partner Content
Abiomed (ABMD) Outpaces Stock Market Gains: What You Should Know
Jan 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close333.74
Today’s open333.33
Day’s range331.18 - 339.41
Volume6,409
Average volume (3 months)666,107
Market cap$13.6B
Data as of 12:09pm ET, 01/22/2019

Growth & Valuation

Earnings growth (last year)+109.92%
Earnings growth (this year)+94.26%
Earnings growth (next 5 years)+49.00%
Revenue growth (last year)+33.34%
P/E ratio81.6
Price/Sales22.47
Price/Book19.41

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+0.61+0.41%
TFXTeleflex Inc+0.10+0.04%
WSTWest Pharmaceutical ...-2.22-2.11%
ZBHZimmer Biomet Holdin...-1.99-1.89%
Data as of 12:10pm ET, 01/22/2019

Financials

Next reporting dateJanuary 31, 2019
EPS forecast (this quarter)$0.94
Annual revenue (last year)$593.7M
Annual profit (last year)$112.2M
Net profit margin18.89%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts